Nov 17, 2016 08:08 am UTC| Business
Solutions use Nokia Bell Labs advanced machine learning algorithms to deliver new levels of proactive care and represent significant first steps in bringing autonomous capabilities to the customer care process.Reduces help...
Global Women's Health Rehabilitation Products Market worth USD 3.30 Billion by 2021
Nov 17, 2016 06:59 am UTC| Business
Sarasota, FL, Nov. 17, 2016 -- Zion Research has published a new report titled “Women's Health Rehabilitation Products Market by Therapy Type (Hand Therapy, Physical Therapy, Occupational Therapy, Massage Therapy,...
Bank Hapoalim Announces Third Quarter 2016 Financial Results
Nov 17, 2016 06:45 am UTC| Business
Net Profit totaled NIS 699 million Return on Equity of 8.3% The Bank reached required Capital Targets Cash Dividend Payout increased to 30% TEL AVIV, Israel, Nov. 17, 2016 -- Bank Hapoalim (TASE:POLI) (ADR:BKHYY),...
AND appoints Bennett Moe as VP Sales to expand business in North America
Nov 17, 2016 06:44 am UTC| Business
CAPELLE AAN DEN IJSSEL, the Netherlands, Nov. 17, 2016 -- AND announced today that it has appointed Bennett Moe as VP Sales North America to help AND expand business in North America. Bennett Moe is a respected sales,...
Sodexo: another year of solid performance; positive outlook
Nov 17, 2016 06:12 am UTC| Business
Revenues up +2.2%, and organic growth[1] of +2.5% On-site organic growth at +2.4% despite a tough economic environment in Remote Sites and a difficult situation in France.Resilient Benefits Rewards Services activity at...
Sodexo launches strategic venture capital fund, dedicated to accompanying innovative start-ups
Nov 17, 2016 06:08 am UTC| Business
PARIS, Nov. 17, 2016 -- Sodexo, world leader in Quality of Life services, announced today the launch of Sodexo Ventures, a 50 million euro venture capital fund, whose investments will combine agility and creativity with...
Targovax ASA: Third quarter 2016 results
Nov 17, 2016 06:05 am UTC| Business
OSLO, Norway, Nov. 17, 2016 -- Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target, primarily, treatment-resistant solid tumors,...